Gregory T. Went
2017
In 2017, Gregory T. Went earned a total compensation of $2.8M as Chief Executive Officer at Adamas Pharmaceuticals, a 9% increase compared to previous year.
Compensation breakdown
| Bonus | $384,244 |
|---|---|
| Option Awards | $1,509,780 |
| Salary | $517,500 |
| Stock Awards | $397,750 |
| Other | $1,058 |
| Total | $2,810,332 |
Went received $1.5M in option awards, accounting for 54% of the total pay in 2017.
Went also received $384.2K in bonus, $517.5K in salary, $397.8K in stock awards and $1.1K in other compensation.
Rankings
In 2017, Gregory T. Went's compensation ranked 3,895th out of 14,666 executives tracked by ExecPay. In other words, Went earned more than 73.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,895 out of 14,666 | 73rd |
Division Manufacturing | 1,362 out of 5,770 | 76th |
Major group Chemicals And Allied Products | 388 out of 2,074 | 81st |
Industry group Drugs | 300 out of 1,730 | 83rd |
Industry Pharmaceutical Preparations | 240 out of 1,329 | 82nd |
Source: SEC filing on April 26, 2018.
Went's colleagues
We found two more compensation records of executives who worked with Gregory T. Went at Adamas Pharmaceuticals in 2017.